A federally funded research team led by Sheri Holmen, PhD, investigator at Huntsman Cancer Institute and professor in the ...
Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...
A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...
A new technique involving ultra-powerful MRI scanners could help doctors identify tiny differences in the brains of people ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
A new technique involving ultra-powerful MRI scanners could help doctors identify tiny differences in the brains of people ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
A new imaging technique is helping ultra-powerful MRI scanners detect tiny differences in the brains of patients with ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback